Cargando…
Drug forecast – the peptide deformylase inhibitors as antibacterial agents
The relatively rapid development of microbial resistance after the entry of every new antimicrobial into the marketplace necessitates a constant supply of new agents to maintain effective pharmacotherapy. Despite extensive efforts to identify novel lead compounds from molecular targets, only the pep...
Autor principal: | Guay, David R P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374925/ https://www.ncbi.nlm.nih.gov/pubmed/18472972 |
Ejemplares similares
-
Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs
por: Gao, Jian, et al.
Publicado: (2016) -
N-Heterocyclic analogues as peptide deformylase inhibitors: Molecular modeling, synthesis and antibacterial evaluation
por: Singh, Anuradha, et al.
Publicado: (2014) -
Structure-Based Drug Design of Small Molecule Peptide Deformylase Inhibitors to Treat Cancer
por: Gao, Jian, et al.
Publicado: (2016) -
Structure and function of a cyanophage-encoded peptide deformylase
por: Frank, Jeremy A, et al.
Publicado: (2013) -
Overexpression of peptide deformylase in breast, colon, and lung cancers
por: Randhawa, Harsharan, et al.
Publicado: (2013)